Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

August 13, 2025

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

August 12, 2025

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

News Industry News

Concept Medical Announces First Patient Enrollment in MAGICAL-SV IDE Trial, Expanding its Coronary Clinical Program Across the U.S. and Europe

August 01, 2025

TCTMD’s Top 10 Most Popular Stories for June 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

Michael O'Riordan

June 30, 2025

Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

News Daily News

Delays in STEMI Treatment Remain Common, Tied to Worse PCI Outcomes

June 13, 2025

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

TCTMD’s Top 10 Most Popular Stories for May 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2025

May 30, 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

News Conference News EuroPCR 2025

Immediate Multivessel PCI May Not Be So Bad in STEMI Patients With Shock: DanGer Data

Yael L. Maxwell

May 20, 2025

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

News Features

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

May 19, 2025

TCTMD’s Top 10 Most Popular Stories for March 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2025

April 01, 2025

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

News Daily News

REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF

Michael O'Riordan

March 11, 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

March 10, 2025

Coverage and Use of Impella and Watchman: A Tale of Four Countries

News Daily News

Coverage and Use of Impella and Watchman: A Tale of Four Countries

Michael O'Riordan

March 04, 2025

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

News Daily News

Danish Analysis Updates Stroke and MI Risks of Contemporary Contraceptives

March 03, 2025

ACC/AHA Release New Comprehensive ACS Guidelines

News Daily News

ACC/AHA Release New Comprehensive ACS Guidelines

February 27, 2025

News Industry News

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

January 30, 2025

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

News Daily News

Coronary Sinus Reducer Overlooked in Review of Stable Angina Treatments

Michael O'Riordan

January 03, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.